Biotech Short Candidates Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Short Candidates

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: rolatzi	10/15/2004 3:11:20 PM
	of 897

Trial Lawyers Seek Next Vioxx Forbes lists new targets for legal action Their list consists of: Eli Lilly - Zyprexa - $4.3 billion sales Glaxo - Paxil - $3.1 billion sales Lilly - Neurontin - $2.7 billion sales Wyeth - Prempro - $1.3 billion sales Pfizer - Dextra - $990 million sales Roche - Accutane - $410 million sales Astra Zeneca - Crestor - $130 million sales Perhaps some of these will make suitable short candidates. A Kerry victory will also spell a top for Drug company stocks, IMHO. Anyone have a sense of which of these will be the best candidates. ciao, rolatzi

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next